In most developed countries, huge amounts of money are allocated to medicine and pharmacology, up to one third of their GDP. This situation, which meets the interests of the population, has become possible to some extent as a result of the consistent implementation of strategies for the development of new highly effective drugs. The activation of these strategies takes place against the background of intensive development of medical chemistry and evaluation of the functional effectiveness of the final product. The monograph under consideration has the most direct relation to the last provision.